Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Join | Sign in
Home>Resources>Books

  Books

Cancer Proteomics

Cancer Proteomics
More information
DNA and RNA Profiling in Human Blood

DNA and RNA Profiling in Human Blood
More information
Gene Silencing

Gene Silencing
More information
Gene Silencing by RNA Interference

Gene Silencing by RNA Interference
More information
Genetic Engineering (v. 25)

Genetic Engineering (v. 25)
More information
Homologous Recombination and Gene Silencing in Plants

Homologous Recombination and Gene Silencing in Plants
More information
RNA Interference in Practice

RNA Interference in Practice
More information
RNAi Technology

RNAi Technology
More information
RNAi: A Guide to Gene Silencing

RNAi: A Guide to Gene Silencing
More information
<< 1 2 >>
showing results 1 to 9 of 11
Scientific News
Acetate Supplements Shown to Speed Up Cancer Growth
A major compound produced in the gut by host bacteria.
Two Cell-Signaling Molecules Found to Suppress the Spread of Melanoma
Findings advance efforts to identify who would benefit from more aggressive therapy at earliest stages.
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
MAGE Genes Provide Insight into Optimizing Chemotherapy
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
Researchers Identify ‘Achilles heel’ in Metabolic Pathway
Achilles heel could lead to new lung cancer treatments.
New Resource to Study the Mechanism and Regulation of Autophagy
New online resource will provide an integrated and systems-level database for autophagy research.
Researchers Discover Possible Mechanism for Faster Evolution
Results hold great promise for gene therapy development.
Yale Team Identifies Key Process In Brain Development
miR-107 shown to play essential role in regulating normal brain development.
Cancer Treatment with KU Origins Enters Second Clinical Trial
Cleave Biosciences has begun a Phase 1 clinical trial to evaluate CB-5083.
Epigenetic Signatures that Differentiate Triple-Negative Breast Cancers
Australian researchers have identified epigenetic ‘signatures’ that could help clinicians tell the difference between highly aggressive and more benign forms of triple-negative breast cancer.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters